BSE
Your Result on : Company News Details
Emcure Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
544210
ISIN Demat
INE168P01015
Book Value (Rs)
216.4487187
NSE Symbol
EMCURE
Divident Yield %
0.15
Market Cap
(Rs In Cr.)
44,378
P/E (TTM)
46.29
EPS (TTM)
50.53
Face Value
(Rs)
10
Back
Emcure Pharmaceuticals consolidated net profit rises 42.05% in the June 2026 quarter
06-Aug-26   Hrs IST

Net profit of Emcure Pharmaceuticals rose 42.05% to Rs 293.98 crore in the quarter ended June 2026 as against Rs 206.95 crore during the previous quarter ended June 2025. Sales rose 22.85% to Rs 2580.45 crore in the quarter ended June 2026 as against Rs 2100.54 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales2580.452100.54 23
OPM %20.6419.84 -
PBDT503.03393.71 28
PBT393.53294.26 34
NP293.98206.95 42

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
BSE Delayed market data sourced at 5 minutes – www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)